Company Profile
GoodRx Stock Price, News & Analysis
- Ticker:
- GDRX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.87 USD (-2.05%)
Close
Last updated: July 23, 2026
999M USD
Market cap
Why the stock is moving
GDRX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
GoodRx is a consumer healthcare platform focused on drug pricing, pharmacy access, and savings tools for patients.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, GoodRx sits in digital health and healthcare services.
Business Model Characteristics
The business depends on consumer traffic, pharmacy relationships, and monetization across savings, subscriptions, and pharma services.
Position Within the Biotechnology Landscape
GoodRx is not a biotech name, but it matters to healthcare because it influences how patients access and pay for medicines.
Future catalysts
GoodRx's catalysts are prescription-marketplace monetization, subscription growth, and pharma-partnership revenue. The stock moves when the consumer-health platform can show better repeatability.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
BRKR · Source: Bruker
- 02
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
DGX · Source: Quest Diagnostics
- 03
Molina Healthcare Reports Second Quarter 2026 Financial Results
MOH · Source: Molina Healthcare
- 04
Axon to Release Second Quarter 2026 Earnings on August 5, 2026
AXON · Source: Axon Enterprise, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of GoodRx (GDRX)?
GoodRx (GDRX) most recently closed at 2.87 USD, a -2.05% move versus the previous session.
What is the market cap of GoodRx (GDRX)?
GoodRx currently has a market capitalization of 999M USD on BioPharmSignal.
What does GoodRx do?
GoodRx is a consumer healthcare platform focused on drug pricing, pharmacy access, and savings tools for patients.
On which exchange is GDRX stock listed?
GoodRx (GDRX) is associated with NASDAQ, United States, Biopharma.
What is GoodRx?
GoodRx's catalysts are prescription-marketplace monetization, subscription growth, and pharma-partnership revenue.
Which conditions is GoodRx targeting with GoodRx?
GoodRx's catalysts are prescription-marketplace monetization, subscription growth, and pharma-partnership revenue.
How does GoodRx describe recent progress with GoodRx?
GoodRx's catalysts are prescription-marketplace monetization, subscription growth, and pharma-partnership revenue.
What future catalysts are investors watching for GoodRx?
GoodRx's catalysts are prescription-marketplace monetization, subscription growth, and pharma-partnership revenue. The stock moves when the consumer-health platform can show better repeatability.